Role of platelet derived growth factor receptor (PDGFR) over-expression and angiogenesis in ependymoma

Journal of Neuro-Oncology

Volumn 111, Issue 2, 2013, Pages 169-176

  Moreno, Lucas ^a   Popov, Sergey ^b   Jury, Alexa ^b   Al Sarraj, Saffa ^c   Jones, Chris ^b   Zacharoulis, Stergios ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Angiogenesis; Children; Ependymoma; PDGF; VEGF

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; ENDOGLIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; STEM CELL FACTOR; VASCULOTROPIN RECEPTOR 2; LEUKOCYTE ANTIGEN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BRAIN PERICYTE; CANCER GRADING; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CAPILLARY DENSITY; CHILD; CLINICAL ARTICLE; ENDOTHELIUM CELL; EPENDYMOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RISK FACTOR; TUMOR CELL; TUMOR LOCALIZATION; TUMOR VASCULARIZATION; DISEASE FREE SURVIVAL; INFANT; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; MORTALITY; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; ANTIGENS, CD; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; EPENDYMOMA; FEMALE; HUMANS; INFANT; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; RETROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

MLCS; MLOWN;

EID: 84879301451     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-012-0996-z     Document Type: Article

References (28)

1. CBTRUS (2010) 2009-2010 CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2004-2006. Central Brain Tumor Registry of the United States, Hinsdale
2. Zacharoulis S, Moreno L (2009) Ependymoma: an update. J Child Neurol 24(11):1431-1438. doi: 10.1177/0883073809339212
3. Pejavar S, Polley MY, Rosenberg-Wohl S, Chennupati S, Prados MD, Berger MS, Banerjee A, Gupta N, Haas-Kogan D (2012) Pediatric intracranial ependymoma: the roles of surgery, radiation and chemotherapy. J Neurooncol 106(2):367-375. doi: 10.1007/s11060-011-0671-9
4. Massimino M, Buttarelli FR, Antonelli M, Gandola L, Modena P, Giangaspero F (2009) Intracranial ependymoma: factors affecting outcome. Future Oncol 5(2):207-216. doi: 10.2217/14796694.5.2.207
5. Massimino M, Gandola L, Giangaspero F, Sandri A, Valagussa P, Perilongo G, Garre ML, Ricardi U, Forni M, Genitori L, Scarzello G, Spreafico F, Barra S, Mascarin M, Pollo B, Gardiman M, Cama A, Navarria P, Brisigotti M, Collini P, Balter R, Fidani P, Stefanelli M, Burnelli R, Potepan P, Podda M, Sotti G, Madon E (2004) Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study. Int J Radiat Oncol Biol Phys 58(5):1336-1345. doi: 10.1016/j.ijrobp.2003.08.030S0360301603018108
6. Zacharoulis S, Ashley S, Moreno L, Gentet JC, Massimino M, Frappaz D (2010) Treatment and outcome of children with relapsed ependymoma: a multi-institutional retrospective analysis. Childs Nerv Syst 26(7):905-911. doi: 10.1007/s00381-009-1067-4
7. Gilhuis HJ, van der Laak JA, Pomp J, Kappelle AC, Gijtenbeek JM, Wesseling P (2006) Three-dimensional (3D) reconstruction and quantitative analysis of the microvasculature in medulloblastoma and ependymoma subtypes. Angiogenesis 9(4):201-208. doi: 10.1007/s10456-006-9054-9
8. Wagemakers M, Sie M, Hoving EW, Molema G, de Bont ES, den Dunnen WF (2010) Tumor vessel biology in pediatric intracranial ependymoma. J Neurosurg Pediatr 5(4):335-341. doi: 10.3171/2009.11.PEDS09260
9. Preusser M, Wolfsberger S, Haberler C, Breitschopf H, Czech T, Slavc I, Harris AL, Acker T, Budka H, Hainfellner JA (2005) Vascularization and expression of hypoxia-related tissue factors in intracranial ependymoma and their impact on patient survival. Acta Neuropathol 109(2):211-216. doi: 10.1007/s00401-004-0938-8
10. Kerbel RS (2008) Tumor angiogenesis. N Engl J Med 358(19):2039-2049. doi: 10.1056/NEJMra0706596
11. Chan AS, Leung SY, Wong MP, Yuen ST, Cheung N, Fan YW, Chung LP (1998) Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma. Am J Surg Pathol 22(7):816-826
12. Green RM, Cloughesy TF, Stupp R, DeAngelis LM, Woyshner EA, Ney DE, Lassman AB (2009) Bevacizumab for recurrent ependymoma. Neurology 73(20):1677-1680. doi: 10.1212/WNL.0b013e3181c1df34
13. Rich JN, Sathornsumetee S, Keir ST, Kieran MW, Laforme A, Kaipainen A, McLendon RE, Graner MW, Rasheed BK, Wang L, Reardon DA, Ryan AJ, Wheeler C, Dimery I, Bigner DD, Friedman HS (2005) ZD6474, a novel tyrosine kinase inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor, inhibits tumor growth of multiple nervous system tumors. Clin Cancer Res 11(22):8145-8157. doi: 10.1158/1078-0432.CCR-05-0319
14. Chuang HC, Su CY, Huang HY, Chien CY, Chen CM, Huang CC (2006) High expression of CD105 as a prognostic predictor of early tongue cancer. Laryngoscope 116(7):1175-1179
15. Dales JP, Garcia S, Bonnier P, Duffaud F, Andrac-Meyer L, Ramuz O, Lavaut MN, Allasia C, Charpin C (2003) CD105 expression is a marker of high metastatic risk and poor outcome in breast carcinomas. Correlations between immunohistochemical analysis and long-term follow-up in a series of 929 patients. Am J Clin Pathol 119(3):374-380
16. Dhar DK, Naora H, Yamanoi A, Ono T, Kohno H, Otani H, Nagasue N (2002) Requisite role of VEGF receptors in angiogenesis of hepatocellular carcinoma: a comparison with angiopoietin/Tie pathway. Anticancer Res 22(1A):379-386
17. Erdem O, Taskiran C, Onan MA, Erdem M, Guner H, Ataoglu O (2006) CD105 expression is an independent predictor of survival in patients with endometrial cancer. Gynecol Oncol 103(3):1007-1011
18. Kyzas PA, Agnantis NJ, Stefanou D (2006) Endoglin (CD105) as a prognostic factor in head and neck squamous cell carcinoma. Virchows Arch 448(6):768-775
19. Saad RS, Jasnosz KM, Tung MY, Silverman JF (2003) Endoglin (CD105) expression in endometrial carcinoma. Int J Gynecol Pathol 22(3):248-253
20. Fonsatti E, Altomonte M, Arslan P, Maio M (2003) Endoglin (CD105): a target for anti-angiogenetic cancer therapy. Curr Drug Targets 4(4):291-296
21. Fonsatti E, Nicolay HJ, Altomonte M, Covre A, Maio M (2010) Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours. Cardiovasc Res 86(1):12-19. doi: 10.1093/cvr/cvp332
22. Ozerdem U, Stallcup WB (2003) Early contribution of pericytes to angiogenic sprouting and tube formation. Angiogenesis 6(3):241-249. doi: 10.1023/B:AGEN.0000021401.58039.a95265361
23. Calzolari F, Malatesta P (2010) Recent insights into PDGF-induced gliomagenesis. Brain Pathol 20(3):527-538. doi: 10.1111/j.1750-3639.2009.00335.x
24. Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG (2000) Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res 60(5):1388-1393
25. Black P, Carroll R, Glowacka D (1996) Expression of platelet-derived growth factor transcripts in medulloblastomas and ependymomas. Pediatr Neurosurg 24(2):74-78
26. Fakhrai N, Neophytou P, Dieckmann K, Nemeth A, Prayer D, Hainfellner J, Marosi C (2004) Recurrent spinal ependymoma showing partial remission under Imatimib. Acta Neurochir (Wien) 146(11):1255-1258. doi: 10.1007/s00701-004-0374- 5
27. Puputti M, Tynninen O, Pernila P, Salmi M, Jalkanen S, Paetau A, Sihto H, Joensuu H (2010) Expression of KIT receptor tyrosine kinase in endothelial cells of juvenile brain tumors. Brain Pathol 20(4):763-770. doi: 10.1111/j.1750-3639.2009.00357.x
28. Ellison DW, Kocak M, Figarella-Branger D, Felice G, Catherine G, Pietsch T, Frappaz D, Massimino M, Grill J, Boyett JM, Grundy RG (2011) Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts. J Negat Results Biomed 10:7. doi: 10.1186/1477-5751-10-7